01 4Pfizer Canada Inc.
02 4Pfizer Canada ULC
01 22285241
02 22344168
03 22613053
04 22688467
01 8BOSUTINIB MONOHYDRATE
01 8TABLET
01 22018-04-02
02 22019-09-22
03 22026-06-28
04 22028-05-30
Patent Expiration Date : 2019-09-22
Date Granted : 2011-04-05
Brand Name : BOSULIF
Patent Number : 2344168
Filing Date : 1999-09-22
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2019-09-22
Date Granted : 2011-04-05
Patent Expiration Date : 2018-04-02
Date Granted : 2013-06-25
Brand Name : BOSULIF
Patent Number : 2285241
Filing Date : 1998-04-02
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2018-04-02
Date Granted : 2013-06-25
Patent Expiration Date : 2028-05-30
Date Granted : 2015-05-12
Brand Name : BOSULIF
Patent Number : 2688467
Filing Date : 2008-05-30
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-05-30
Date Granted : 2015-05-12
Patent Expiration Date : 2018-04-02
Date Granted : 2013-06-25
Brand Name : BOSULIF
Patent Number : 2285241
Filing Date : 1998-04-02
Strength per Unit : 500 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2018-04-02
Date Granted : 2013-06-25
Patent Expiration Date : 2019-09-22
Date Granted : 2011-04-05
Brand Name : BOSULIF
Patent Number : 2344168
Filing Date : 1999-09-22
Strength per Unit : 500 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2019-09-22
Date Granted : 2011-04-05
Patent Expiration Date : 2028-05-30
Date Granted : 2015-05-12
Brand Name : BOSULIF
Patent Number : 2688467
Filing Date : 2008-05-30
Strength per Unit : 500 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-05-30
Date Granted : 2015-05-12
Patent Expiration Date : 2026-06-28
Date Granted : 2015-11-24
Brand Name : BOSULIF
Patent Number : 2613053
Filing Date : 2006-06-28
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-06-28
Date Granted : 2015-11-24
Patent Expiration Date : 2026-06-28
Date Granted : 2015-11-24
Brand Name : BOSULIF
Patent Number : 2613053
Filing Date : 2006-06-28
Strength per Unit : 500 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-06-28
Date Granted : 2015-11-24
